WRITTEN IN PLAIN AMERICAN ENGLISH.
About
CLAY TRIBUNE.
ShopCartAccount
Advertisement

Edgewell’s North America Rebounds While Margins Collapse

Edgewell's North America division rebounds, but profit margins collapse under inflation, tariffs and restructuring charges.

By mitch·4 min read
A dark corporate boardroom with a financial dashboard showing falling numbers.

In its latest report for the third quarter of fiscal 2026, Edgewell Personal Care has released numbers that tell two separate stories. The North American division finally showed signs of improvement, while profit margins suffered significantly. Rod Little, the CEO, described the situation “an important step forward,” though the rest of the fiscal year will determine whether that description holds up.

North America Finally Shows Life

The company reported net sales of $570.1 million, an increase of 1.7% over last year’s figure. Organic net sales grew 1.1%, marking the first time that measure has risen in a while. The actual significance lies within that figure.

Organic sales in North America rose 3.0%, driven by volume increases in Sun, Skin Care and Grooming. The company points to improved execution, expanded distribution and growing strength in its key brands as the reasons behind the gain. This marks a turnaround for the region, which investors have been watching closely for several quarters.

Advertisement

The Sun and Skin Care division reported a solid increase in revenue. Net sales climbed 5.7%, with organic sales rising 5.0%. The growth was driven by mid-single-digit gains in Sun Care in North America alongside strong performance from Grooming and Skin Care worldwide.

EPS was kept at $0.72, the same as last year and more than what the company had been hinting at. Adjusted EBITDA reached $78.9 million, topping the company’s own targets. Interest costs fell to $16.7 million from $19.4 million, which came about after the revolving credit facility was paid down using the money from the Feminine Care divestiture.

With $397.1 million in cash and another $418.8 million available on that facility, Edgewell still has room to keep funding its turnaround while paying a $0.15 per share dividend.

Margins Get Hammered

Gross margin fell 210 basis points to 42.5%, with even the adjusted figure slipping 30 basis points to 44.5%. The quarter’s discomfort came from the cost side of the business, where core inflation and tariffs moved faster than any productivity savings could keep up with.

The advertising budget rose to 14.6% of sales from 13.6%, while SG&A climbed to 19.0% from 18.0%, with higher incentive pay pushing it up. The company also took on $24.5 million in restructuring charges for the quarter, which pushed operating income down to $25.0 million from $45.0 million.

GAAP diluted EPS dropped to $0.26 from $0.46.

“An important step forward.”

Rod Little’s remark came from his own office. He described the North American recovery as a sign of improvement, though the profit figures show a harder path.

Wet Shave And International Struggles

The Wet Shave segment failed to lift performance. Private label supply constraints linked to the company’s own manufacturing consolidation weighed on sales, which declined organically by 1.9%. Profit for the segment dropped nearly 25% on an organic basis.

Sales abroad fell 1.4%, weighed down by turmoil from the fighting in the Middle East.

The company has raised its full-year restructuring costs forecast to roughly $92 million, up from the earlier $90 million estimate. Its adjusted net debt leverage remains at 3.7 times.

What This Quarter Means For Investors

North America has shown real progress in the right direction during the quarter, though the profit situation remains troubling. Gross margin declined by 210 basis points, operating income was cut nearly in half, and the Wet Shave segment posted a loss of 1.9%.

Edgewell’s financial standing remains solid. The firm holds $397.1 million in cash and retains an additional $418.8 million on its revolving credit line. This funding provides enough breathing room for the company to bankroll its turnaround efforts while continuing to pay a $0.15 per share dividend.

There is no denying the cost pressure is genuine. Productivity gains are being overtaken by inflation and tariffs, while restructuring charges continued to accumulate.

The key for investors is monitoring whether the North American momentum can persist while keeping the profit hit from reaching other divisions. The firm remains in the opening phase of its turnaround, and the coming quarters will reveal whether the execution gains endure.

Here is the quick breakdown of the key figures:

  • Net sales: $570.1 million, up 1.7% from a year ago
  • Organic net sales: +1.1% (first growth in a while)
  • North America organic sales: +3.0%
  • Sun and Skin Care net sales: +5.7%; organic: +5.0%
  • Adjusted EPS: $0.72, matching prior year
  • Adjusted EBITDA: $78.9 million, ahead of plan
  • Gross margin: down 210 basis points to 42.5%
  • Operating income: collapsed to $25.0 million from $45.0 million
  • GAAP diluted EPS: $0.26 from $0.46
  • Restructuring charges: $24.5 million for the quarter
  • Full-year restructuring costs: now $92 million (up from $90 million estimate)

Whether the North American recovery can overcome the margin pressure will determine the company’s path forward. The next few quarters will reveal the whole tale.

The Notebook

Get the Notebook.

The day's best stories and every fresh verdict, in plain English, in your inbox by seven. One email a day, no more.

We send one note to confirm. Every issue has a one-click way out.

Advertisement

Leave a Reply

Your email address will not be published. Required fields are marked *

As an Amazon Associate, Clay Tribune earns from qualifying purchases.